Bilol

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bilol

What is Bilol? Identity and Pharmacological Class

The following overview defines the core identity, composition, and classification of the medicinal preparation Bilol, strictly focusing on the nature of the drug entity.

Property Description
Active ingredient Bisoprolol Fumarate
Form Oral film-coated tablet
Pharmacological class Beta-blocker (beta1-adrenergic receptor antagonist)
General purpose Supports heart function and stabilizes circulation
Origin Synthetic

Bilol is a prescription-only medicine whose active ingredient is Bisoprolol Fumarate, a synthetic compound. Its classification places it firmly within the high-level pharmacological group of beta-blockers, or beta-adrenergic receptor antagonists. This class of medication is effective in reducing the effects of adrenaline on the heart and blood vessels.

Bilol is specifically defined as a cardioselective beta1-blocker. This key property means that the drug preferentially targets the beta1 receptors found predominantly in the heart muscle, making it a targeted sympatolytic drug. Pharmacological studies have widely confirmed this selective mechanism, distinguishing it from older, non-selective beta-blockers. The active substance, Bisoprolol Fumarate, is chemically known to be a racemic mixture.

Composition, Form, and General Therapeutic Purpose

The medication is formulated as a single-ingredient product, presented for the oral route of administration as a film-coated tablet. This allows for systemic absorption of the active ingredient. The primary general therapeutic purpose of this medication is to support heart function by reducing its overall workload and promoting a calmer, more stable rhythm. This mechanism makes it a frequently utilized tool in therapeutic strategies focused on managing chronic cardiac strain.

Regulatory References

  1. NIH MedlinePlus

What side effects are possible with Bilol?

Possible Side Effects and Safety Information

Bilol (often associated with the drug class of beta-blockers, such as bisoprolol, in general safety literature) possesses a safety profile that is primarily characterized by cardiovascular and neurological adverse reactions, as documented in authoritative regulatory and medical sources. The majority of reported adverse events are mild to moderate and often relate to its primary mechanism of action.

Key Adverse Reaction Categories and Frequency

Adverse reactions are generally classified by system-organ class. The most frequently reported adverse reactions typically involve the Nervous System (e.g., dizziness, headache, fatigue), the Gastrointestinal System (e.g., diarrhea, nausea, vomiting), and the Vascular System (e.g., feeling of coldness in extremities). These effects are generally classified as Common (affecting up to 1 in 10 people).

Serious and Clinically Significant Adverse Reactions

While uncommon, clinically significant adverse reactions must be monitored. These may include the worsening of existing heart failure, severe bradycardia (abnormally slow heart rate), and certain conduction disturbances like heart block. Bronchospasm (difficulty breathing, especially in patients with pre-existing pulmonary conditions like asthma) is also considered a critical safety concern.

Safety-Related Restrictions and Considerations

  • Abrupt Cessation: The medication must not be stopped suddenly, particularly in patients with coronary artery disease, as this can lead to serious cardiovascular events, including exacerbated angina or myocardial infarction. Dosage must be gradually reduced under medical guidance.
  • Population-Specific: Use requires particular caution in patients with uncontrolled heart failure, severe bradycardia, certain types of heart block, or severe peripheral circulatory disturbances. Lower doses and careful monitoring may be required in patients with compromised kidney or liver function.
  • Monitoring: Regular monitoring of heart rate, blood pressure, and signs of heart failure exacerbation is necessary during treatment. The drug may mask signs of hypoglycemia (low blood sugar) or hyperthyroidism, necessitating vigilant monitoring in affected patients.

This summary provides high-level safety information based on established regulatory standards for this drug class and is not intended as a substitute for the official product labeling or clinical consultation.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents define the overdose profile of Bilol (Bisoprolol Fumarate) based on several critical systemic effects. The principal manifestations documented include severe bradycardia (abnormally slow heart rate), pronounced hypotension (low blood pressure), bronchospasm (airway tightening), and hypoglycemia (low blood sugar). Overdose may progress to life-threatening conditions such as Acute Cardiac Failure, Heart Block, seizures, and coma.

Immediate medical attention is mandated for all suspected overdose symptoms due to the risk of these severe and life-threatening complications. Regulatory guidance requires prompt action, starting with the discontinuation of Bilol therapy.

Management Summary

Domain Official Regulatory Statement
Antidote Availability No specific antidote is known for Bisoprolol overdose.
Management Approach Symptomatic and supportive treatment must be provided.
Monitoring Close monitoring of vital signs, including heart rate, blood pressure, and ECG, is required.

Therapeutic Uses of Bilol

What Bilol Treats: Main Uses and Benefits

Bilol (Bisoprolol Fumarate) is a foundational medication relevant for managing conditions characterized by heightened physiological stress. This agent is used to manage hypertension and support circulatory stability. The drug is considered relevant across core therapeutic domains for supportive symptom management, including the management of chronic high blood pressure, chronic stable angina pectoris, and stable chronic heart failure.

For patients, this medication is applied when additional management of discomfort is required during phases of increased distress. The therapeutic intent is to offer supportive relief when symptoms interfere with routine activities, helping to maintain a sense of stability when symptoms are more noticeable.

Management of Chronic High Blood Pressure

Bilol is a foundational long-term treatment relevant for managing sustained control of elevated arterial pressure (Hypertension). This supports the management of significant cardiovascular risk and may provide support that contributes to reducing certain cardiovascular risks, such as heart attack and stroke.

Quick Fact: Relief for Exertional Chest Discomfort

Bilol is relevant for easing symptoms related to organ-specific functional stress, specifically the recurrent chest discomfort and heaviness of stable angina. It may assist with reducing the frequency and intensity of these episodes, contributing to improved comfort during periods of heightened symptoms.

Regulatory References

  1. NIH DailyMed Drug Information

Eligibility and Restrictions for Use

Bilol (Bisoprolol Fumarate) is permitted for use only in adults who do not have any contraindications listed in the official regulatory documents. Use in children and adolescents under 18 years of age is not recommended, as safety and efficacy have not been established by regulatory authorities. For older adults, use is generally permitted, though caution is advised with co-existing conditions.

Bilol is strictly contraindicated and must not be used in patients with:

  • Acute heart failure or decompensation requiring intravenous therapy.
  • Cardiogenic shock or severe bradycardia (very slow heart rate).
  • Second or third-degree AV block (a type of severe heart rhythm disturbance).
  • Severe bronchial asthma or severe chronic obstructive pulmonary disease (COPD).
  • Metabolic acidosis or untreated pheochromocytoma.

Regulatory restrictions also apply based on physiological status. The medicine is not recommended during pregnancy unless clearly necessary, and it is not recommended while breastfeeding. Specific caution and potential dose adjustments are required for patients with severe renal impairment or severe hepatic impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The co-administration of Bilol (Bisoprolol Fumarate) with certain medicines is officially classified based on the potential for altered exposure or enhanced pharmacodynamic effects on the heart and circulation.

Restricted and Prohibited Combinations

The co-administration of Bilol with other beta-blocking agents is prohibited due to the risk of additive beta-adrenergic blocking action. Combinations with specific Calcium Antagonists (Verapamil-type and Diltiazem-type) are not generally recommended, as they may potentiate the depression of atrio-ventricular conduction and contractility. Similarly, Class I Antiarrhythmic Agents and Centrally-Acting Antihypertensives carry an increased risk and are used with care.

Pharmacokinetic and Procedural Constraints

Official labeling notes a pharmacokinetic interaction with Rifampin, which increases Bisoprolol's metabolic clearance, leading to a shortened elimination half-life. Bilol absorption is officially documented as being unaffected by general food intake. Furthermore, in patients receiving Clonidine, Bilol must be discontinued for several days before the withdrawal of the other agent to manage associated risks.

Concomitant Use Cautions

Interactions involving additive effects are documented with Digitalis Glycosides and Anesthetic Agents that depress myocardial function, increasing the risk of bradycardia and hypotension. For diabetic patients using insulin or oral hypoglycemic agents, Bisoprolol may mask specific manifestations of hypoglycemia, such as tachycardia, requiring caution during co-administration.

Mechanism of Action

How Bilol Works

Bilol's primary pharmacodynamic mechanism involves competitive antagonism of the beta1-adrenergic receptors, which are highly concentrated in the myocardium and the cardiac pacemaker cells. This molecular interaction prevents endogenous catecholamines, such as norepinephrine, from binding and initiating the G s protein signaling cascade.

This blockade yields two direct systemic consequences: a negative chronotropic effect (reduced heart rate) and a negative inotropic effect (reduced force of contraction). The combined action leads to a decrease in cardiac output and lowered myocardial oxygen consumption.

Additionally, Bilol acts peripherally by blocking beta1-receptors on the kidney's juxtaglomerular cells. This suppresses the release of renin, thereby modulating the initial step of the Renin-Angiotensin-Aldosterone System (RAAS) cascade. The resulting limitation of the vasoconstrictor Angiotensin II contributes to a decrease in systemic vascular tone and arterial blood pressure.

Dosage and Administration Information

How to Use Bilol

Bilol (Bisoprolol Fumarate) is formulated as an oral film-coated tablet, and the instructions for its use are based on the specific condition being managed. The medicine is prescribed for once daily administration, with the suggestion that the dose be taken preferably in the morning. The tablets must be swallowed whole with liquid and may be taken with or without food. They should not be crushed or chewed, as this may interfere with the intended release of the active ingredient.


Official Dosing Patterns

The established dosing regimens vary significantly depending on the indication:

  • Hypertension and Angina: The standard initial dose is 5 mg once daily. Dosing may be adjusted to a typical maintenance range of 5 mg to 10 mg, up to a maximum recommended dose of 20 mg once daily.

  • Stable Chronic Heart Failure: Use for this condition requires a slow titration regimen. Treatment starts at a low dose of 1.25 mg once daily, which is gradually doubled at weekly or four-weekly intervals up to a maximum maintenance dose of 10 mg once daily.


Procedural Constraints

Bilol is generally intended for long-term therapy. If treatment needs to be stopped, it is an essential procedural condition that the dose must be slowly and gradually reduced over approximately one week. Abrupt discontinuation is strictly avoided. Furthermore, for patients identified with severe renal or hepatic impairment, the daily dose must not exceed 10 mg. If a dose is missed, the advice is to take it as soon as remembered, unless the next dose is almost due, in which case the missed dose should be skipped to prevent doubling the dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Bilol


Evidence for the Management of Stable Chronic Heart Failure

Research exploring Bilol (Bisoprolol Fumarate) in stable chronic heart failure has centered on large-scale Randomized Controlled Trials (RCTs) and meta-analyses. These rigorous studies often involved thousands of adults who had reduced heart function (Left Ventricular Ejection Fraction le 35%), frequently alongside existing standard therapy. The primary outcomes monitored were survival time and the frequency of hospitalization related to heart failure.

These major trials documented patterns related to the frequency of hospitalization and changes in all-cause mortality tracked over the study period. The studies also monitored functional measures like LVEF to quantify changes in cardiac function. Findings from meta-analyses are included in the broader research base for this chronic condition.

What remains uncertain is the approach for patients experiencing an acute phase of illness; research was focused on stable patients. Studies also provide limited data for individuals whose heart failure is complicated by concurrent atrial fibrillation.


Evidence for the Control of Chronic High Blood Pressure (Hypertension)

Research for Bilol's use in hypertension has relied on Randomized Controlled Trials (RCTs) that compared the medication against placebo or established anti-hypertensive drugs. These studies were designed to monitor outcomes related to systemic imbalance, specifically measuring the change in systolic and diastolic blood pressure in adults over defined time intervals.

The findings from these trials reported measurements showing that the medication was observed to be associated with changes in blood pressure and heart rate measurements. Findings documented that changes in the primary biomarker (blood pressure) were recorded in the study populations.

While the evidence indicates an observed change in the blood pressure biomarker, there is less extensive long-term comparative evidence when the drug is used solely for uncomplicated hypertension, compared to other drug classes. Information for certain specialized or high-risk patient subgroups is insufficient.


Long-Term Follow-up and Durability of Response

Long-term research is most established within stable chronic heart failure. The largest trials monitored crucial hard outcomes, such as all-cause mortality and heart failure hospitalization, over follow-up durations extending past one year. These findings describe group patterns related to the durability of the monitored outcomes.

Key Studies & References

  1. Bisoprolol Fumarate Tablet, Film Coated (Official FDA Label/DailyMed)

Frequently Asked Questions (FAQ)

Common questions about Bilol (FAQ)

Q: What is the main difference between Bilol and other drugs that treat the same condition?

Bilol is classified in official documents as a selective beta1-blocker (cardioselective) at its recommended therapeutic doses. This means it exhibits high selectivity for beta1 receptors, which are predominantly found in the heart, distinguishing it from non-selective beta-blockers.

Q: Is it normal to feel a bit dizzy when first starting Bilol?

Dizziness and lightheadedness are common reported side effects listed in the official product information for Bilol. These effects are often noted to occur when treatment is first initiated or when the dosage is increased.

Q: Do I need to change my diet while taking Bilol?

According to the official product information, Bilol tablets can be taken with or without food. There are no specific dietary restrictions related to the drug's absorption or efficacy.

Q: How is Bilol different from the drug ending in '-pril'?

Bilol is classified as a beta-blocker. In contrast, drugs often ending in '-pril' (ACE inhibitors) target a different step in the body's Renin-Angiotensin System to achieve their effect.

Q: How does Bilol's mechanism of action compare to a calcium channel blocker?

Official warnings advise caution regarding combination use with certain types of calcium channel blockers (such as verapamil or diltiazem) due to an increased risk of profound hypotension and depressed electrical conduction in the heart.

Q: Is Bilol the same as a water pill (diuretic)?

Bilol is classified as a beta-blocker, not a diuretic (water pill). While Bilol is sometimes used together with diuretics, its main mechanism is beta1-receptor blockade and not increased urine output.

Q: Does taking Bilol affect blood sugar levels?

Official warnings state that Bilol may mask the symptoms of low blood sugar (hypoglycemia), such as a rapid heart rate, in individuals who are also taking insulin or other diabetes medications.

Q: Why do doctors prescribe Bilol instead of other options sometimes?

Bilol is described in regulatory documents as a highly selective beta1-adrenoceptor blocking agent (cardioselective). This specific characteristic is noted in its therapeutic profile, distinguishing it from other treatment options.

Q: Is Bilol used for heart rhythm problems (arrhythmias)?

Bilol's pharmacological mechanism includes effects that decrease heart rate and affect the electrical conduction pathways of the heart. Its primary therapeutic uses are for conditions like hypertension, angina, and chronic heart failure.

Q: Does Bilol help prevent heart attacks or strokes?

Clinical studies primarily monitored crucial outcomes in stable chronic heart failure patients, tracking a reduction in sudden death and fewer hospital admissions related to heart failure.

Q: What research has been done on Bilol for younger adults?

Official labeling confirms that the safety and effectiveness of Bilol have not been established in patients under 18 years old. Its use in children and adolescents is therefore not recommended by regulatory authorities.

Q: Is it possible to become resistant to the effects of Bilol over time?

Long-term clinical trials tracking outcomes in patients with chronic heart failure and hypertension have demonstrated sustained efficacy and consistent blood pressure and heart rate reductions over extended periods.

Q: Is Bilol generally considered well-tolerated?

According to the official product labeling, many reported adverse reactions are classified as common and are typically described as mild to moderate. Common reported effects include fatigue and dizziness.

Q: What is the risk of Bilol causing low blood pressure?

Hypotension (low blood pressure) is listed in official documents as a common adverse reaction. This risk may be higher during the initial period when a person starts taking the medication.

Q: How quickly does Bilol typically start to affect the body?

Pharmacological studies indicate that the maximal effect of Bilol in reducing the heart rate is generally observed within 1 to 4 hours after a dose is taken.

Q: Are there any common supplements that interact with Bilol?

Regulatory guidance advises caution regarding herbal remedies and supplements because their safety in combination with Bilol is not formally established. Official warnings note that multivitamins with minerals may affect the absorption of Bisoprolol.

Q: Can Bilol affect my sleep schedule?

Yes, official product information reports that insomnia (difficulty sleeping) and nightmares are listed side effects of the medication.

Q: Are there warnings about driving or operating machinery when taking Bilol?

Official patient counseling cautions that Bilol may cause dizziness or lightheadedness, and requires caution against driving or operating hazardous machinery until they are familiar with how the medicine affects them.

Q: Does Bilol have a generic version available?

Yes, the active ingredient, Bisoprolol Fumarate, has been approved by the FDA as a generic drug.

Q: Is Bilol known to cause weight gain?

Weight gain is a reported adverse reaction. In the context of heart failure, sudden or unusual weight gain is listed as a specific sign that requires immediate medical attention.

Q: What is the typical duration of action for Bilol?

Official pharmacological data indicates that the effects of the medication generally persist for 24 hours when taken at doses of 5 mg or greater. This supports its once-daily administration.

Q: Is it possible for Bilol to interact with common pain relievers like ibuprofen?

Yes, official drug interaction warnings note that the long-term use of certain Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), such as ibuprofen, may reduce the blood pressure-lowering effect of Bilol.

Q: Are there specific symptoms that require immediate medical attention while on Bilol?

Official warnings specify that signs of an allergic reaction (such as swelling of the face or throat) or symptoms of worsening heart failure (such as sudden weight gain or irregular breathing) require immediate medical attention.

Q: Does Bilol interact with alcohol?

Yes, official patient counseling warns that consuming alcohol (ethanol) may have an additive effect in lowering blood pressure. Due to the potential for additive effects, caution regarding alcohol consumption is included in patient counseling.

Q: What are the common signs of an allergic reaction to Bilol?

Signs of a serious allergic reaction, as defined in the official product information, include developing hives, difficulty breathing, or swelling of the face, lips, tongue, or throat.

Q: Are there any common herbal remedies that interact with Bilol?

Official guidance notes that the safety of combining the medicine with herbal remedies is not formally established or consistently tested in the same way as prescription medicines. Official guidance notes that the use of herbal remedies should be disclosed to a healthcare provider.

Q: Does Bilol affect fertility?

Animal studies conducted on male and female rats using high doses of Bisoprolol Fumarate showed no impairment of fertility.

Q: Can Bilol affect mood or cause depression?

Yes, depression and changes in mood are listed in the official documents as reported adverse reactions of the medication.

Q: Does Bilol interact with widely used anti-depressants?

Yes, official regulatory guidance indicates that some antidepressants can also lower blood pressure. Taking them with Bilol may cause the blood pressure to drop too low due to additive effects.

Q: Can taking Bilol cause a cough?

The official adverse reactions data reports that cough is listed as a less common side effect associated with the use of this medication.

Q: Does Bilol affect cholesterol levels?

Official product information reports that changes in cholesterol and increases in serum triglycerides have been noted as laboratory abnormalities in clinical trials.

How should Bilol be stored and disposed of?

How to Store and Dispose of Bisoprolol Fumarate (Bilol)

Official Storage and Handling

Bisoprolol Fumarate tablets must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F), and must not be allowed to freeze. The medication requires protection from moisture and excess heat. Keep the tablets in their original, tightly closed container and store them out of the sight and reach of children at all times.

Official Disposal Instructions

Unused or expired tablets should be discarded following local regulations. The preferred method is to utilize a drug take-back program. If this is not available, the medication may be mixed with an undesirable substance (such as dirt or coffee grounds) and sealed in a container before disposal in the household trash. The tablets must not be disposed of via wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bilol found in:

A-Z Index: